CS Paper Radar

Brain-PACE: A Deep Siamese MRI Framework for Modelling Longitudinal Brain Acceleration

Samuel Maddox, Jacob Newman, Saber Sami, Michal Mackiewicz, for the Alzheimer's Disease Neuroimaging Initiative, the Australian Imaging Biomarkers, Lifestyle flagship study of ageing

cs.CV ·submitted 2026-09-10 11:14 UTC · v1

Abstract

Brain age estimation has become a popular research proxy for assessing brain health and disease, yet longitudinal trajectories of brain ageing are still poorly defined, and clinical use is limited. Building on existing Siamese longitudinal frameworks, we develop Brain-Predicted Age Acceleration (Brain-PACE) to directly estimate the pace of structural brain ageing from paired T1-weighted MRI. Brain-PACE identified accelerated ageing in $42.6$% of participants with mild cognitive impairment. Faster Brain-PACE was associated with greater functional and cognitive impairment (FAQ; $r=0.35$, ADAS13; $r=0.30$, CDR-SB; $r=0.32$) and greater regional tau burden in the posterior cingulate ($r=0.59$), precuneus ($r=0.47$), and entorhinal cortex ($r=0.37$). These associations were stronger than those observed when pace was calculated indirectly from repeated cross-sectional brain age estimates, suggesting that direct longitudinal modelling captures complementary information relevant to ongoing pathological change. Methodologically, Brain-PACE extends the LILAC framework by combining spatial attention with soft label distribution learning and a Cramér distance objective, improving probabilistic performance and reducing prediction bias while providing measures of predictive uncertainty. Together, these findings support Brain-PACE as a complementary longitudinal imaging phenotype with sensitivity to relevant clinical and biological changes in early neurodegeneration.

Comment
20 pages, 6 figures

Closest papers

Nearest neighbours by meaning across the whole index.

Covariate-Conditioned One-Step Diffusion for Multi-Horizon 3D Brain MRI Prediction in Aging and Neurodegeneration

eess.IV cs.AIcs.CVcs.LG ·2026-11-05 ·Natenaile Asmamaw Shiferaw, Ali Farki, Deepika Koundal, Jussi Tohka
code/data similarity 0.63
Abstract · 5 pages, 2 figures, 4 tables. Submitted to IEEE ISBI 2027

Predicting longitudinal brain changes from magnetic resonance imaging (MRI) can help characterize structural progression associated with aging and neurodegeneration. However, diffusion-based forecasting typically requires iterative denoising, limiting inference efficiency. We propose a covariate-conditioned one-step diffusion framework for multi-horizon prediction of 3D gray-matter density (GMD) maps. Rather than directly generating future anatomy, the model predicts longitudinal GMD changes through residual prediction in a single denoising step. The predicted changes are added to the baseline GMD map to reconstruct future anatomy. The model is conditioned on baseline anatomy, age, diagnosis, APOE4 allele count, and continuous follow-up time. Training combines mean squared error with a Pearson correlation loss to improve the spatial agreement between predicted and observed GMD changes. A unified model supports prediction horizons from 2 to 10 years. On the held-out ADNI test set, our method achieves a $Δ$-Pearson of 0.478, mean squared error (MSE) of $5.176 \times 10^{-3}$, and structural similarity index measure (SSIM) of 0.979, with $Δ$-Pearson reaching 0.582 at 10 years. Without retraining, external evaluation on AIBL yields a $Δ$-Pearson of 0.450, MSE of $4.016 \times 10^{-3}$, and SSIM of 0.985. Ablation studies further demonstrate the benefits of residual prediction, covariate conditioning, and correlation-based supervision. Code: https://github.com/natenaile/OneStepBrainMRI.

0.34

Covariance Eigenspace Provides Latent Attribution of Longitudinal Effects in Brain Age Gap

eess.SP q-bio.QM ·2026-09-30 ·Jason Scheffel, Saurabh Sihag
similarity 0.60
Abstract

Brain age gap is a promising machine learning (ML)-driven bio\-marker of accelerated biological aging and is derived from neuroimaging data. Recent works on coVariance neural networks (VNN) for brain age gap prediction have provided an explainable and anatomically verifiable framework for brain age gap prediction. Notably, VNN outcomes are derived by filtering inputs along covariance eigenvectors, providing a mechanism for explaining their decisions in terms of latent (orthogonal) vectors. In this paper, we investigate the longitudinal brain age gap effects in a Mild Cognitive Impairment (MCI) cohort using a VNN-driven brain age gap prediction framework. Specifically, using Integrated Gradients (IG) as the attribution mechanism, our results demonstrate that the eigenspectrum of the anatomical covariance matrix explains the different longitudinal effects observed in brain age gap in amyloid positive vs amyloid negative subcohorts more prominently than individual brain regions ($83.2\%$ with the leading eigenvector versus a maximal value of $7.7\%$ for any brain region). Therefore, the covariance-based latent explanation identifies a key coordinated input pattern that carries most of the observed longitudinal effect in brain age gap.

0.26

CoFlu-Brain: An fMRI Connectivity Foundation Model with Cofluctuation-Based Pretraining

cs.NE ·2026-10-11 ·Ziteng Sui, Junfeng Xia, Wenhao Ye, Mo Wang, Quanying Liu
code/data similarity 0.59
Abstract

Functional magnetic resonance imaging (fMRI) commonly characterizes large-scale brain organization through functional connectivity (FC). However, an observed FC matrix is not a fixed brain graph but a statistical estimate determined by the finite BOLD frames used to compute it. Conventional FC-based approaches typically represent each scan with a single Pearson-correlation matrix, leaving frame-resolved variations in regional interactions unexploited. To address this limitation, we introduce CoFlu-Brain, which organizes framewise cofluctuation observations into multiple retained and dropped views, each summarized as an FC matrix. The model learns connectivity structure reproducible across retained views and predicts the representations of the corresponding dropped views, while adopting SIGReg from LeJEPA to prevent representation collapse. We pretrained CoFlu-Brain on 13,444 subjects from eight dataset groups and evaluated its representations via frozen-encoder linear probing on seven classification and two age-prediction tasks across seven datasets. CoFlu-Brain showed strong transfer across demographic, developmental, and clinical prediction tasks, outperforming the evaluated released models on most tasks. Random frame partitioning improved aggregate transfer, while the complete objective achieved the strongest overall performance. Code is available.

0.20

Longitudinal Bayesian Learning of Continuous Disease Position across the Alzheimer's Disease Continuum

cs.LG cs.AIq-bio.QM ·2026-08-19 ·Yingying Zhang, Kun Zhao, Guodong Liu, Qi Huang, Pengfei Gu +8 more
similarity 0.57
Abstract

Alzheimer's disease (AD) progresses as a continuous biological process, whereas most existing neuroimaging-based artificial intelligence methods remain limited to discrete diagnosis or clinical score prediction from cross-sectional imaging. In this work, we propose Disease Continuum Positioning (DCP), a longitudinal Bayesian Learning framework that continuously estimates disease severity from longitudinal diffusion tensor imaging (DTI). Specifically, DCP models disease severity as a low-dimensional probabilistic latent variable by jointly integrating longitudinal observations with weak clinical supervision, from which the proposed Disease Continuum Score (DCS) is derived to quantify an individual's position along the Alzheimer's disease continuum together with its associated uncertainty. Extensive experiments on the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort demonstrate that DCP consistently outperforms representative disease progression methods. More importantly, comprehensive validation analyses show that DCS accurately characterizes disease severity, exhibits strong clinical relevance, preserves longitudinal disease evolution, and predicts future disease conversion. These results suggest that DCS provides a quantitative imaging-derived representation for continuous assessment of Alzheimer's disease progression beyond conventional diagnostic labels and clinical scores.

0.19

Clinical Pathways Matter for Multimodal Deep Learning in Early Alzheimers Disease Detection

eess.IV ·2026-08-17 ·Yao Lu, Solveig Kristina Hammonds, Alvaro Fernandez-Quilez
published similarity 0.57
Abstract · Published

Identifying individuals at risk of Alzheimer's disease (AD), particularly in the preclinical and early stages, remains challenging. Although deep learning approaches based on structural MRI show promise as a non-invasive biomarker, existing multimodal models require task-specific training and depend on biomarkers that are not routinely available in clinical practice. Here, we propose a zero-shot multimodal framework based on SigLIP that combines structural MRI embeddings with text embeddings of routinely collected clinical variables for early AD risk stratification in individuals at preclinical or mild cognitive impairment (MCI) stages. We evaluated the approach in 416 individuals from the ADNI cohort (age: 72.73 +- 6.7). SigLIP was used without fine-tuning to extract MRI and clinical text embeddings, which were combined into multimodal representations for individual-level AD risk prediction within 4 years. We further compared the model performance in a single-visit and two-visit settings to assess the value of longitudinal information and framework scalability. In the single-visit setting, combining MRI embeddings with MMSE, age, and sex achieved an AUC of 0.91 +- 0.02, outperforming both a CSF A\b{eta}42-based model (AUC 0.73 +- 0.08) and an MMSE-based model (AUC 0.85 +- 0.22). In the two-visit setting, performance was maintained or improved, supporting the scalability of the approach to longitudinal data. These findings suggest that zero-shot multimodal fusion of structural MRI and routinely collected clinical variables may provide a practical and scalable strategy for early AD risk stratification without task-specific retraining.

0.48

BrainDiff: Longitudinal Report Generation for Multimodal Brain MRI

cs.CV ·2026-09-01 ·Krish Patel, Peirong Liu
code/data similarity 0.57
Abstract · 13 pages, 3 figures

Neuroradiologists rarely read a brain MRI in isolation, yet automated brain-MRI report generation has been built almost entirely for single studies. Temporal analysis has been explored on chest radiography and chest CT, but to our knowledge, longitudinal reporting for brain MRI, where interval change is often subtle and spatially distributed, remains unaddressed. We present BrainDiff, the first longitudinal vision-language system for brain MRI. BrainDiff outperforms both frontier general-purpose and single-study neuroimaging models on the same patient pairs. Moreover, BrainDiff retains 91% of internal RadGraph-XL entity+relation F1 (rg_er) on an external, cross-hospital cohort. Beyond the system, we contribute three analyses. First, we identify two independent grounding levers: a counterfactual objective with prior-report dropout, which increases measured image reliance by ~47%, and a staged curriculum. Together, these interventions raise image reliance 2.5-fold from the baseline. Second, we provide a factorial over prior-report availability and image identity, isolating a visual contribution of +0.0387 rg_er, which grows when the prior report is withheld. Third, a cheap change-decodability test for candidate backbones shows that interval change is decodable far more weakly than single-study pathology (0.60 vs. 0.77 AUROC). Code is publicly available at https://github.com/jhuldr/BrainDiff.

0.45

Leakage-Controlled Multimodal Learning for Diagnosis and Progression Prediction in Alzheimer's Disease Research

cs.LG ·2026-10-07 ·Akeem Temitope Otapo, Ghazaleh Khodabandelou, Zuheng Ming, Alice Othmani
similarity 0.57
Abstract

Alzheimer's disease prediction involves irregular visits, heterogeneous measurements and incomplete modalities. This study presents a multimodal multitask framework combining an adapted SFCN MRI encoder, four causal clinical Transformers, shared fusion and task-specific ODE-GRU dynamics. Fine-tuning and LoRA adapt the final two MRI blocks. Task-DRO balances task losses, while Group-CVaR targets cohort and comorbidity strata. Branch-specific input controls, subject-grouped partitions and empirical causality checks support longitudinal evaluation. Across 2,649 subjects and 17,317 visits from ADNI, OASIS-2 and MIRIAD, internal validation yields diagnosis, stage-1 progression and first-stage-1-visit progression AUROCs of 0.935 +/- 0.002, 0.884 +/- 0.003 and 0.870 +/- 0.005, respectively (mean +/- SD across three seeds). Corresponding hybrid AUROCs are 0.951, 0.909 and 0.896. Next-visit MMSE mean absolute error (MAE) is 1.61 points; worst-stratum diagnosis AUROC is 0.827 +/- 0.008. Sampled ADNI explanations identify task-specific input dependence. OASIS-3 external validation yields network and hybrid diagnosis AUROCs of 0.763 and 0.767, hybrid next-visit progression AUROC of 0.764, diagnosis calibration error decreasing from 0.197 to 0.052, and next-visit MMSE MAE of 0.86. Seed-42 paired ablations of six components yield pooled diagnosis and progression AUROC differences between -0.004 and +0.004; removing clinical encoder inputs lowers diagnosis AUROC by 0.272. The framework integrates longitudinal prediction, missing-modality handling, auxiliary comorbidity modelling and subgroup evaluation within a common pipeline.

0.11

ELPAC: Endpoint-Anchored Latent Progression with Stage-Varying Multimodal Coordination

cs.LG stat.MLstat.ME ·2026-11-05 ·Shengxian Ding, Yifei Zhang, Xinyuan Tian, Yuanshuang Guo, Yize Zhao
published similarity 0.57
Abstract · NeurIPS 2026

Aging cohorts increasingly combine imaging, plasma, and cognitive measurements, but most subjects provide only a partially observed cross-sectional snapshot, leaving latent stage, progression subtype, and stage-varying multimodal coordination to be inferred jointly. Existing methods estimate the cohort-level aging process, model covariance under observed covariates, or fuse modalities for prediction. However, they rarely target the joint problem of endpoint-anchored staging and progression-resolved residual coordination across modalities, even though subject staging, subtype assignment, and multimodal interplay are mutually dependent. We introduce ELPAC, a Bayesian framework with two interlocking constructions. The first integrates subtype trajectories backward from clinically reliable endpoint groups along biologically structured velocity components encoding modality-specific monotone direction and optional sequential ordering priors. The second factorizes residual multimodal variation around the inferred stage axis into sparse coordination axes whose loadings and activations expose which multimodal patterns are operative in each subtype and when they emerge, with stage-resolved variation supplying the auxiliary structure for conditional identifiability. We use a scalable amortized variational inference scheme that enables joint posterior inference at cohort scale with single-pass deployment on new subjects. On synthetic data and a harmonized ADNI+NACC/SCAN Alzheimer's cohort, ELPAC demonstrates accurate latent-structure recovery, well-calibrated prediction intervals, and biologically interpretable multimodal coordination programs that differ by subtype.

0.21